Details for Patent: 9,629,842
✉ Email this page to a colleague
Which drugs does patent 9,629,842 protect, and when does it expire?
Patent 9,629,842 protects MODEYSO and is included in one NDA.
This patent has thirty-nine patent family members in seventeen countries.
Summary for Patent: 9,629,842
| Title: | Small molecule TRAIL gene induction by normal and tumor cells as an anticancer therapy |
| Abstract: | Methods and compositions relating to TIC10 are described according to aspects of the present invention. The compositions and methods have utility in treating disease, particularly cancer in a subject in need thereof, including a human subject as well as subjects of other species. The compositions have utility in treating brain cancer in a subject in need thereof. |
| Inventor(s): | Wafik S. El-Deiry, Joshua E. Allen, Gen Sheng Wu |
| Assignee: | Penn State Research Foundation |
| Application Number: | US15/269,114 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; Dosage form; |
Drugs Protected by US Patent 9,629,842
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chimerix | MODEYSO | dordaviprone hydrochloride | CAPSULE;ORAL | 219876-001 | Aug 6, 2025 | RX | Yes | Yes | 9,629,842 | ⤷ Start Trial | METHOD OF TREATING ADULT AND PEDIATRIC PATIENTS 1 YEAR OF AGE AND OLDER WITH DIFFUSE MIDLINE GLIOMA HARBORING AN H3 K27M MUTATION WITH PROGRESSIVE DISEASE FOLLOWING PRIOR THERAPY | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,629,842
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2832342 | ⤷ Start Trial | |||
| Cyprus | 1123010 | ⤷ Start Trial | |||
| Denmark | 2701708 | ⤷ Start Trial | |||
| Denmark | 3679934 | ⤷ Start Trial | |||
| European Patent Office | 2701708 | ⤷ Start Trial | |||
| European Patent Office | 3679934 | ⤷ Start Trial | |||
| European Patent Office | 4335511 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
